The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2015

Filed:

Feb. 26, 2013
Applicant:

Allergan, Inc., Irvine, CA (US);

Inventors:

Rahul C. Mehta, San Marcos, CA (US);

Elizabeth Tsin Ho Makino, Carlsbad, CA (US);

Sujatha D. Sonti, San Marcos, CA (US);

John A. Garruto, Encinitas, CA (US);

Assignee:

Allergan, Inc., Irvine, CA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/35 (2006.01); A61Q 19/02 (2006.01); A61K 8/33 (2006.01); A61K 31/047 (2006.01); A61K 31/07 (2006.01); A61K 31/122 (2006.01); A61K 31/375 (2006.01); A61K 31/445 (2006.01); A61K 36/484 (2006.01); A61K 8/67 (2006.01); A61K 8/97 (2006.01); A61K 8/49 (2006.01);
U.S. Cl.
CPC ...
A61K 8/33 (2013.01); A61K 31/047 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/375 (2013.01); A61K 31/445 (2013.01); A61K 36/484 (2013.01); A61K 8/671 (2013.01); A61Q 19/02 (2013.01); A61K 8/97 (2013.01); A61K 2800/92 (2013.01); A61K 8/35 (2013.01); A61K 8/4926 (2013.01);
Abstract

A method for the modification of melanin distribution, and the composition thereof to modify melanin distribution are disclosed. A method for the reduction of melanin distribution, and the composition thereof to reduce melanin distribution are disclosed. A representative composition comprises 4-ethoxybenzaldehyde and one or more additional active agents as well as a pharmaceutically acceptable carrier or excipient. Carriers and excipients may be formulated for topical administration. Compositions may also be formulated for transdermal administration. The compositions may be used for the prevention and treatment of pigmentation disorders, by way of non-limited example, post-inflammatory hyperpigmentation and others. The compositions may be used for lightening skin.


Find Patent Forward Citations

Loading…